Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
HELP
HELP
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
HELP News
Helus Pharma Advances New Drug for Anxiety Treatment
Mar 09 2026
Newsfilter
Helus Pharma Advances Mental Health Treatments with Promising Phase 2 Results
Mar 09 2026
PRnewswire
Helus Pharma's Anxiety Drug Trial Results Trigger Stock Plunge
Mar 06 2026
stocktwits
US Stock Futures Stabilize Amid Oil Price Surge
Mar 06 2026
stocktwits
Helus Pharma's HLP004 Phase 2 Study Results Disappoint
Mar 05 2026
Benzinga
GAD Therapies Market Expected to Reach $4.26B by 2033 Amid Rising Demand
Mar 05 2026
PRnewswire
GAD Therapies Market Expected to Reach $4.26B by 2033 Amid Rising Demand
Mar 05 2026
Newsfilter
Helus Pharma Reports Significant Phase 2 Trial Results for Anxiety Disorder Therapy
Mar 05 2026
seekingalpha
Helus Pharma Reports Promising Early Results for HLP004 Anxiety Treatment
Mar 05 2026
stocktwits
Helus Pharma Announces Phase 2 Results for HLP004 in GAD Treatment
Mar 05 2026
Newsfilter
Helus Pharma Advances Mental Health Drug Development
Feb 27 2026
Newsfilter
Helus Pharma Advances Psychedelic Drug Clinical Trials
Feb 27 2026
PRnewswire
Helus Pharma's Psychedelic Drug Achieves Phase 3 Success
Feb 26 2026
PRnewswire
Helus Pharma Achieves Breakthrough in Depression Treatment
Feb 26 2026
Newsfilter
Mental Health Treatment Market Set for Accelerated Growth
Feb 24 2026
PRnewswire
Mental Health Drug Market Set for Accelerated Growth
Feb 24 2026
Newsfilter
Show More News
